Literature DB >> 14756737

Are health expectations of term breech infants unrealistically high?

Veli-Matti Ulander1, Mika Gissler, Mika Nuutila, Olavi Ylikorkala.   

Abstract

BACKGROUND: The aim of this study was to compare the effect of fetal presentation and mode of delivery on infant outcome in a nation-wide study.
METHODS: In a retrospective observational cohort study, we compared, with the help of Finnish Medical Birth Register and other nation-wide registers, the short-term and long-term outcome of infants born by breech vaginal (n = 1270) or by vertex vaginal delivery (n = 128,683) or through planned cesarean section (CS) in breech (n = 1640) or vertex (n = 4997); the pregnancies were otherwise entirely normal.
RESULTS: One perinatal death occurred in the breech vaginal group and 23 deaths in the vertex vaginal group (p = 0.112), but none in either CS group. Breech vaginal delivery was associated with increased risk of Apgar scores 6 or less at age 1 min (OR 7.65, CI 6.41-9.12) and at age 5 min (OR 6.42, CI 4.36-9.45) as compared with vertex vaginal delivery. These odd ratios were also elevated (OR 4.59, CI 3.48-7.08 and OR 7.58, CI 3.09-18.66, respectively) when compared with breech planned CS. Yet the risk for birth trauma of infants in the breech vaginal group was smaller (OR 0.70, CI 0.51-0.96) than that in the vertex vaginal group but this risk was smallest in the planned CS groups. A number of other neonatal complications occurred equally commonly in each group. Breech infants born vaginally needed fewer admissions (OR 0.58, 0.47-0.72) to out-patient departments and the cumulative incidence of long-term morbidity in the breech vaginal group was smaller (OR 0.47, CI 0.28-0.80) to the age of 7 years than that in the breech planned CS. The maturity for starting school and school performance during the first two school years showed no dependence on mode of delivery.
CONCLUSION: Apart from Apgar suppression, elective vaginal delivery of a full-term breech fetus in highly selected pregnancies does not cause additional neonatal hazards as compared with full-term vertex deliveries. The immediate outcome was best for breech or vertex infants born through elective CSs.

Entities:  

Mesh:

Year:  2004        PMID: 14756737     DOI: 10.1111/j.0001-6349.2004.00386.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  6 in total

1.  The intelligence quotient of school aged children delivered by cesarean section and vaginal delivery.

Authors:  Nayereh Khadem; Talaat Khadivzadeh
Journal:  Iran J Nurs Midwifery Res       Date:  2010

2.  Cardiotocography in breech versus vertex delivery: an examiner-blinded, cross-sectional nested case-control study.

Authors:  Elli Toivonen; Outi Palomäki; Heini Huhtala; Jukka Uotila
Journal:  BMC Pregnancy Childbirth       Date:  2016-10-21       Impact factor: 3.007

3.  Impact of implementation of a breech clinic in a tertiary hospital.

Authors:  S Derisbourg; E Costa; L De Luca; S Amirgholami; V Bogne Kamdem; A Vercoutere; W H Zhang; S Alexander; P M Buekens; Y Englert; A Pintiaux; C Daelemans
Journal:  BMC Pregnancy Childbirth       Date:  2020-07-29       Impact factor: 3.007

4.  Revisiting the management of term breech presentation: a proposal for overcoming some of the controversies.

Authors:  Lionel Carbillon; Amelie Benbara; Ahmed Tigaizin; Rouba Murtada; Marion Fermaut; Fatma Belmaghni; Alexandre Bricou; Jeremy Boujenah
Journal:  BMC Pregnancy Childbirth       Date:  2020-05-03       Impact factor: 3.007

5.  [Breech vaginal delivery: a study of maternal and neonatal morbidity and mortality].

Authors:  Olivier Mukuku; Julien Kimbala; Justin Kizonde
Journal:  Pan Afr Med J       Date:  2014-01-17

6.  Neonatal Mortality and Long-Term Outcome of Infants Born between 27 and 32 Weeks of Gestational Age in Breech Presentation: The EPIPAGE Cohort Study.

Authors:  Elie Azria; Gilles Kayem; Bruno Langer; Laetitia Marchand-Martin; Stephane Marret; Jeanne Fresson; Véronique Pierrat; Catherine Arnaud; François Goffinet; Monique Kaminski; Pierre-Yves Ancel
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.